Yesterday, Apple and Google announced that they have teamed up to make it easier to switch between Android and iPhone devices. The companies say they have developed new features that make it easier ...

Two more Apple products, specifically Maps and Ads, could be big enough to be designated as gatekeepers under the European Union’s Digital Markets Act (DMA). The EU has announced that it has received ...

Apple today shared a study commissioned from Analysis Group [PDF] that looks at App Store pricing changes before and after reduced fees took effect in the EU in March 2024 under the Digital Markets ...

Instead of just arguing the benefits of Apple's ecosystem, the company is going on the offensive and challenging the core legality of the European Union's Digital Markets Act in court in an ...

Last night, Apple issued its most forceful rebuttal yet to Europe’s Digital Markets Act (DMA), which may force it to open up its ecosystem. Today, the European Commission shot back. Here are the ...

Explore how digital feedback controllers manage motors, pressure, temperature, and more, and learn why ADC and DAC performance are crucial when designing robust embedded systems. How to define the ...

KILLEEN— After more than two decades in uniform, U.S. Army Master Sgt. Fabian Balarezo is living proof that personal growth doesn’t end with rank, and that education can be a bridge between military ...

A headline on Nielsen's Insights newsletter web page asked this question: “What is a Designated Market Area (DMA), and why does it matter?” The piece then goes on to explain the concept of DMAs, ...

Apple AAPL-0.15%decrease; red down pointing triangle said it will delay offering some planned new features to users in the European Union this year because regulations are making it harder to bring ...

Apple Appeals DMA, Says EU Has ‘Deeply Flawed Rules’ That ‘Stifle Innovation’ Your email has been sent Apple is appealing EU demands to open iOS to third-party devices, arguing interoperability ...

After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, AbbVie is advancing its solid tumor ambitions with a new FDA green light.